HLB Pep Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 89

Employees

  • Stock Symbol
  • 196300

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $2.34
  • (As of Monday Closing)

HLB Pep General Information

Description

HLB Pep Co Ltd is engaged in peptide biomaterials and new drug development.

Contact Information

Formerly Known As
Anygen
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Rm.206, Pilot plant, Gwangju Technopark
  • 333, Cheomdangwagi-ro, Buk-gu
  • Jeonnam-Gwangju, 61008
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Corporate Office
  • Rm.206, Pilot plant, Gwangju Technopark
  • 333, Cheomdangwagi-ro, Buk-gu
  • Jeonnam-Gwangju, 61008
  • South Korea
+82

HLB Pep Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HLB Pep Stock Performance

As of 16-Nov-2026, HLB Pep’s stock price is $2.34. Its current market cap is $22M with 9.4M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.34 $2.51 $2.20 - $6.58 $22M 9.4M 29.7K -$0.08

HLB Pep Financials Summary

As of 30-Sep-2026, HLB Pep has a trailing 12-month revenue of $3.89M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 26,665 31,444 52,728 71,655
Revenue 3,886 3,486 4,565 4,291
EBITDA 3,015 2,758 (2,869) (4,138)
Net Income (997) (451) (4,979) (6,944)
Total Assets 36,278 37,366 11,214 16,292
Total Debt 13,972 11,737 5,370 5,702
Public Fundamental Data provided by Morningstar, Inc. disclaimer

HLB Pep Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HLB Pep‘s full profile, request access.

Request a free trial

HLB Pep Patents

HLB Pep Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250109170-A1 Method for manufacturing ganirelix Pending 01-Dec-2021
WO-2023101490-A1 Novel method for manufacturing ganirelix Inactive 01-Dec-2021
WO-2023090935-A1 Method for producing agm peptides that bind specifically to nucleolin Inactive 18-Nov-2021
JP-2024517582-A Composition for preventing or treating inflammatory bowel disease containing a novel compound Active 09-Sep-2021
JP-7627783-B2 Composition for preventing or treating inflammatory bowel disease containing a novel compound Active 09-Sep-2021 C07K5/1024
To view HLB Pep’s complete patent history, request access »

HLB Pep Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HLB Pep Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HLB Pep‘s full profile, request access.

Request a free trial

HLB Pep Investments (1)

HLB Pep’s most recent deal was a Corporate Asset Purchase with Dongyoon Seon (8,218.9 Square Meter Portfolio of Land and Building in Cheongju, South Korea) for . The deal was made on 21-Feb-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dongyoon Seon (8,218.9 Square Meter Portfolio of Land and Building in Cheongju, South Korea) 21-Feb-2017 Corporate Asset Purchase Buildings and Property
To view HLB Pep’s complete investments history, request access »

HLB Pep ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view HLB Pep’s complete esg history, request access »

HLB Pep FAQs

  • When was HLB Pep founded?

    HLB Pep was founded in 2000.

  • Where is HLB Pep headquartered?

    HLB Pep is headquartered in Jeonnam-Gwangju, South Korea.

  • What is the size of HLB Pep?

    HLB Pep has 89 total employees.

  • What industry is HLB Pep in?

    HLB Pep’s primary industry is Drug Discovery.

  • Is HLB Pep a private or public company?

    HLB Pep is a Public company.

  • What is HLB Pep’s stock symbol?

    The ticker symbol for HLB Pep is 196300.

  • What is the current stock price of HLB Pep?

    As of 16-Nov-2026 the stock price of HLB Pep is $2.34.

  • What is the current market cap of HLB Pep?

    The current market capitalization of HLB Pep is $22M.

  • What is HLB Pep’s current revenue?

    The trailing twelve month revenue for HLB Pep is $3.89M.

  • What is HLB Pep’s annual earnings per share (EPS)?

    HLB Pep’s EPS for 12 months was -$0.08.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process